| US 7,524,884 B2 | ||
| Compacted 2,2-dibromo-3-nitrilopropionamide | ||
| Michael Lupin, Haifa (Israel); Ayala Lupin, legal representative; and David Feldman, Haifa (Israel) | ||
| Assigned to Bromine Compounds Limited, (Israel) | ||
| Appl. No. 10/381,527 PCT Filed Sep. 26, 2001, PCT No. PCT/IL01/00911 § 371(c)(1), (2), (4) Date Oct. 06, 2003, PCT Pub. No. WO02/26699, PCT Pub. Date Apr. 04, 2002. |
||
| Claims priority of application No. 138771 (IL), filed on Sep. 28, 2000. | ||
| Prior Publication US 2004/0054002 A1, Mar. 18, 2004 | ||
| Int. Cl. A01N 37/34 (2006.01); A01N 43/30 (2006.01) | ||
| U.S. Cl. 514—528 [514/464] | 11 Claims |
| 1. A compacted 2,2-Dibromo-3-nitrilopropionamide (DBNPA) in a form selected from the group consisting of granular form, tablets, briquettes and pellets, free from binders and/or fillers, consisting essentially of at least 97 wt% of DBNPA and the balance comprising water, wherein said compacted DBNPA was compressed in a compactor. |